Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE

Annals of the Rheumatic Diseases

Volumn 74, Issue 4, 2015, Pages 791-792

  Humrich, Jens Y ^a   Spee Mayer, Caroline Von ^a   Siegert, Elise ^a   Alexander, Tobias ^a   Hiepe, Falk ^a   Radbruch, Andreas ^b   Burmester, Gerd Rüdiger ^a   Riemekasten, Gabriela ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDESLEUKIN; IMMUNOLOGIC FACTOR; INTERLEUKIN 2;

ADULT; ARTHRITIS; CASE REPORT; DISEASE ACTIVITY; FEMALE; HUMAN; HYPOCOMPLEMENTEMIA; LETTER; LOW DRUG DOSE; MORNING STIFFNESS; MULTIPLE CYCLE TREATMENT; MYALGIA; MYOSITIS; PRIORITY JOURNAL; RASH; REMISSION; SINGLE DRUG DOSE; SWELLING; SYSTEMIC LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84925652648     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206506     Document Type: Letter

References (7)

1. Fontenot JD, Rasmussen JP, Gavin MA, et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005;6:1142-51.
2. Setoguchi R, Hori S, Takahashi T, et al. Homeostatic maintenance of natural Foxp3 (+) CD25 (+) CD4 (+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005;201:723-35.
3. Humrich JY, Morbach H, Undeutsch R, et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci USA 2010;107:204-9.
4. Saadoun D, Rosenzwajg M, Joly F, et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 2011;365:2067-77.
5. Koreth J, Matsuoka K-I, Kim HT, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 2011;365:2055-66.
6. Gutierrez-Ramos JC, Andreu JL, Revilla Y, et al. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature 1990;346:271-4.
7. Mizui M, Koga T, Lieberman LA, et al. IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8-IL-17-producing T cells. J Immunol 2014;193:2168-77.